The Legal Abuse of Prescription Drugs: Evidence of a Continuing Drug Problem

Balter M.B. 1973 “An analysis of psychotherapeutic drug consumption in the United States.” In: Anglo-American Conference of Drug Abuse, 16–18 April, 1973. London: The Royal Society of Medicine.

Balter M. B. Levine J. 1971 “Character and extent of psychotherapeutic drug usage in the United States.” Excerpta Medica International Congress Series No. 274, Psychiatry (Part I). Excerpta Medica, Amsterdam, 80–88.

Biron P. 1973 “A hopefully biased pilot survey of physicians' knowledge of the content of drug combinations.” Canadian Medical Association Journal, 109: 35, 37, 39.

Blackwell B. 1973 “Psychotropic drugs in use today. The role of diazepam in medical practice.” JAMA, 225: 1637–1641.

Capel W.C. Knapp R.J. 1977 “Legal pushing: A study in over-reaction to a fancied menace.” J. Drug Issues, 7: 195–201.

Cooperstock R. 1974 “Some factors involved in the increased prescribing of psychotropic drugs.” In: Cooperstock R. , Ed. Social Aspects of the Medical Use Of Psychotropic Drugs. Toronto: Addiction Research Foundation.

Cooperstock R. 1975 “Epidemiology of problems associated with prescription drug use in Canada.” In: Rootman I. Billard D. , eds. Epidemiology of Drug-Related Problems in Canada, 1975. Ottawa: Health and Welfare Canada.

Crout J.R. 1974 “Prescription drugs advertising.” Drugs and Cosmetic Industry, 114: 46.

Davidson J.R.T. Raft D. Lewis B.F. Gebhardt M. 1975 “Psychotropic drugs on general medical and surgical wards of a teaching hospital.” Arch. Gen. Psychiat. 32:507–511.

Dunlop D. 1970 “Abuse of drugs by the public and by doctors.” British Medical Bulletin, 26:236–239.

Gavel M. 1973 “Corporate pushers: The only thing amusing about the ethical drug industry is its name.” In: Smith D.E. Wesson D.R. , Uppers and Downers, Englewood Cliffs, N.J.: Prentice-Hall.

Greenblatt D.J. Shader R.I. 1974 “The price we pay.” In: Greenblatt D.J. Shader R.I. , eds. Benzodiazepines in Clinical Practice, New York: Raven Press.

Greenblatt D.J. Shader R.I. Koch-Weser J. 1975 “Psychotropic drug use in the Boston area. A report from the Boston collaborative drug surveillance program.” Arch. Gen. Psychiat., 32:518–521.

Kaufman A. Brickner P.W. Verner R. Mashburn W. 1972 “Tranquilizer control.” JAMA, 221:1504–1506.

Lancet 1973 “Benzodiazepines: Use, overuse, misuse, abuse?” Lancet, 1 (7812): 1101–1102.

Lennard H.L. Epstein L.J. Bernstein A. Ranson D.C. 1971 “Mystification by the medical profession.” In: Lennard H.L. , Ed. Mystification and Drug Misuse: Hazards in Using Psychoactive Drugs, San Francisco: Jossey-Bass.

Lewis D.C. 1971 Statement made before the Subcommittee on Monopoly, Senate Small Business Committee, July 22, 1971, Washington: U.S. Government Printing Office, Select Committee on Small Business, pp. 769–780.

Maronde R.F. Burks D. Lee P.U. Light P. McCarron M.M. McCary M. Seibert S. 1969 “Physician prescribing practices.” Am. J. of Hosp. Pharm., 26: 566–572.

Maronde R.F. Seibert S. Katzoff U. Silverman M. 1972 “Prescribing data processing - its role in the control of drug abuse.” California Medicine, 117:22–28.

Muller C. 1972 “The overmedicated society: Forces in the market place for medical care.” Science, 176:488–492.

Prather J.E. Fidell L.S. 1972 “Pressures for prescribing psychoactive drugs to women.” Paper presented to the American Sociological Association, New Orleans.

Seidenberg R. 1971 “Drug advertising and perception of mental illness.” Mental Hygiene, 55: 21–31.

Sims M. 1972 “Family practitioners and the prescription of psychoactive drugs.” Canadian Family Physician, 18: 79–84.